KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) EBT (2016 - 2025)

Elevance Health (ELV) has disclosed EBT for 17 consecutive years, with $1.4 billion as the latest value for Q3 2025.

  • On a quarterly basis, EBT rose 2.4% to $1.4 billion in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.1 billion, a 113.06% decrease, with the full-year FY2024 number at $7.9 billion, up 2.45% from a year prior.
  • EBT was $1.4 billion for Q3 2025 at Elevance Health, up from -$3.3 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $3.0 billion in Q2 2024 to a low of -$44.1 billion in Q4 2021.
  • A 5-year average of -$1.0 billion and a median of $1.7 billion in 2023 define the central range for EBT.
  • Peak YoY movement for EBT: tumbled 7311.46% in 2021, then skyrocketed 254.47% in 2022.
  • Elevance Health's EBT stood at -$44.1 billion in 2021, then surged by 102.37% to $1.0 billion in 2022, then decreased by 4.21% to $1.0 billion in 2023, then tumbled by 39.46% to $606.0 million in 2024, then surged by 132.01% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's EBT are $1.4 billion (Q3 2025), -$3.3 billion (Q2 2025), and $246.0 million (Q1 2025).